New York, NY — AV Laboratories, a leader in luxury skincare rooted in biotechnology and longevity science, has named Roula Youssef Halabi to its Business Advisory Board as part of its strategic push into the UAE and Middle East markets.
Halabi, a veteran healthcare executive with over 20 years of experience, currently serves as Senior Vice President at CooperSurgical. She also sits on the board of Mecomed, a regional medical technology association, where she advocates for improved patient access, ethical healthcare practices, and regulatory advancement across the Middle East.
In her new advisory role, Halabi will help guide AV Laboratories’ expansion efforts in the region, where demand for science-driven skincare is rapidly accelerating.
“Today’s consumers—especially in markets like Dubai—are seeking clinical-grade skincare solutions that align with the precision and rigor of personalized medicine,” Halabi said. “AV Laboratories’ commitment to science-backed products and its focus on skin longevity positions it as a leader in this space. I’m excited to contribute to the company’s growth and innovation.”
AV Laboratories, which combines 25 years of stem cell science with a minimalist luxury approach, is gaining international attention for its high-performance skincare products that promise clinically validated results. The company has identified the UAE as a key growth market, citing increasing demand for evidence-based beauty solutions.
“Roula’s strategic insight into the wellness and life sciences sectors, coupled with her deep understanding of regional market dynamics, makes her a critical addition to our team,” said Ami Mezezi, CEO and Co-Founder of AV Laboratories. “Her expertise in women’s health, innovation, and business development will help us accelerate our presence in the Middle East.”
Multilingual and internationally experienced, Halabi brings a global perspective to the board. Her background as a trained midwife and her commitment to women’s health further align with AV Laboratories’ science-first philosophy.
The appointment marks a significant milestone in AV Laboratories’ global expansion strategy as it continues to pioneer the intersection of biotechnology, skincare, and longevity.
